Skip Navigation

JNCI Monographs 2004 2004(33):126-133; doi:10.1093/jncimonographs/lgh004
© 2004 by Oxford University Press
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Gotay, C. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gotay, C. C.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

2004 © Oxford University Press

Article

Assessing Cancer-Related Quality of Life Across a Spectrum of Applications

Carolyn Cook Gotay, Ph.D.,

Cancer Research Center of Hawaii, University of Hawaii, Honolulu, HI 96813 (e-mail: cgotay{at}crch.hawaii.edu).

Health-related quality of life (HRQOL) is increasingly assessed to understand the effects of cancer and cancer-related interventions. At the macro level, monitoring HRQOL in the population and in cancer survivors may be important to track progress against cancer and evaluate the outcome of policies and programs. At the meso level, where most research, to date, has been focused, HRQOL data may be used in descriptive and analytic studies to understand the impact of cancer, patterns of care, and effects of interventions for cancer prevention, treatment, and continuing care. At the micro level, HRQOL data can inform individual patient and clinician decision making. Current data show that validated and commonly used HRQOL questionnaires are not interchangeable. Consequently, in determining which HRQOL measures are most appropriate for a given application, it is especially important to carefully consider both the study hypotheses and patient population. Future progress at all levels requires better understanding of the meaning and interpretation of HRQOL scores.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J Natl Cancer Inst MonogrHome page
J. Lipscomb, M. S. Donaldson, and R. A. Hiatt
Cancer Outcomes Research and the Arenas of Application
J Natl Cancer Inst Monographs, October 1, 2004; 2004(33): 1 - 7.
[Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.